Welcome!

News Feed Item

Migraine Global Clinical Trials Review, H2, 2013

NEW YORK, Oct. 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Migraine Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Migraine Global Clinical Trials Review, H2, 2013" provides data on the Migraine clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Migraine. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Migraine. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Migraine 6
Report Guidance 6

Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Migraine 23
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Migraine Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33

Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
Allergan, Inc. 42
Clinical Trial Overview of Allergan, Inc. 42
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Banyan Group, Inc. 48
Clinical Trial Overview of Banyan Group, Inc. 48
NuPathe Inc. 49
Clinical Trial Overview of NuPathe Inc. 49
Endo Health Solutions Inc. 50
Clinical Trial Overview of Endo Health Solutions Inc. 50

Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Top Institutes / Government 52
Danish Headache Center 52
Clinical Trial Overview of Danish Headache Center 52
Thomas Jefferson University 54
Clinical Trial Overview of Thomas Jefferson University 54
Montefiore Medical Center 55
Clinical Trial Overview of Montefiore Medical Center 55
Johns Hopkins University 56
Clinical Trial Overview of Johns Hopkins University 56
The Cleveland Clinic 57
Clinical Trial Overview of The Cleveland Clinic 57
Chengdu University of Traditional Chinese Medicine 58
Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 58
University of Pittsburgh 59
Clinical Trial Overview of University of Pittsburgh 59
Glostrup University Hospital 60
Clinical Trial Overview of Glostrup University Hospital 60
Shahid Beheshti University 61
Clinical Trial Overview of Shahid Beheshti University 61
Swedish Medical Center 62
Clinical Trial Overview of Swedish Medical Center 62

Five Key Clinical Profiles 63
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112


List of Tables
Migraine Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries, 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries, 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Migraine Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Migraine Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 33
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 39
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 42
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 44
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 46
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Banyan Group, Inc., 2013* 48

Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by NuPathe Inc., 2013* 49
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Health Solutions Inc., 2013* 50
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexza Pharmaceuticals, Inc., 2013* 51
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Headache Center, 2013* 52
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013* 54
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Montefiore Medical Center, 2013* 55
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 56
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 57
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2013* 58
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 59
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2013* 60
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2013* 61
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Medical Center, 2013* 62

List of Figures
Migraine Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 110

To order this report: Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

__________________________
Contact Clare: [email protected]
US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As data explodes in quantity, importance and from new sources, the need for managing and protecting data residing across physical, virtual, and cloud environments grow with it. Managing data includes protecting it, indexing and classifying it for true, long-term management, compliance and E-Discovery. Commvault can ensure this with a single pane of glass solution – whether in a private cloud, a Service Provider delivered public cloud or a hybrid cloud environment – across the heterogeneous enter...
"IoT is going to be a huge industry with a lot of value for end users, for industries, for consumers, for manufacturers. How can we use cloud to effectively manage IoT applications," stated Ian Khan, Innovation & Marketing Manager at Solgeniakhela, in this SYS-CON.tv interview at @ThingsExpo, held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Onalytica. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
Extracting business value from Internet of Things (IoT) data doesn’t happen overnight. There are several requirements that must be satisfied, including IoT device enablement, data analysis, real-time detection of complex events and automated orchestration of actions. Unfortunately, too many companies fall short in achieving their business goals by implementing incomplete solutions or not focusing on tangible use cases. In his general session at @ThingsExpo, Dave McCarthy, Director of Products...
Regulatory requirements exist to promote the controlled sharing of information, while protecting the privacy and/or security of the information. Regulations for each type of information have their own set of rules, policies, and guidelines. Cloud Service Providers (CSP) are faced with increasing demand for services at decreasing prices. Demonstrating and maintaining compliance with regulations is a nontrivial task and doing so against numerous sets of regulatory requirements can be daunting task...
Fact: storage performance problems have only gotten more complicated, as applications not only have become largely virtualized, but also have moved to cloud-based infrastructures. Storage performance in virtualized environments isn’t just about IOPS anymore. Instead, you need to guarantee performance for individual VMs, helping applications maintain performance as the number of VMs continues to go up in real time. In his session at Cloud Expo, Dhiraj Sehgal, Product and Marketing at Tintri, sha...
The Internet of Things (IoT) promises to simplify and streamline our lives by automating routine tasks that distract us from our goals. This promise is based on the ubiquitous deployment of smart, connected devices that link everything from industrial control systems to automobiles to refrigerators. Unfortunately, comparatively few of the devices currently deployed have been developed with an eye toward security, and as the DDoS attacks of late October 2016 have demonstrated, this oversight can ...
Machine Learning helps make complex systems more efficient. By applying advanced Machine Learning techniques such as Cognitive Fingerprinting, wind project operators can utilize these tools to learn from collected data, detect regular patterns, and optimize their own operations. In his session at 18th Cloud Expo, Stuart Gillen, Director of Business Development at SparkCognition, discussed how research has demonstrated the value of Machine Learning in delivering next generation analytics to impr...
Join Impiger for their featured webinar: ‘Cloud Computing: A Roadmap to Modern Software Delivery’ on November 10, 2016, at 12:00 pm CST. Very few companies have not experienced some impact to their IT delivery due to the evolution of cloud computing. This webinar is not about deciding whether you should entertain moving some or all of your IT to the cloud, but rather, a detailed look under the hood to help IT professionals understand how cloud adoption has evolved and what trends will impact th...